FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

870524004: Eptinezumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3969939011 Eptinezumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3969940013 Eptinezumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3969939011 Eptinezumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3969940013 Eptinezumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eptinezumab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Eptinezumab (substance) Has disposition Calcitonin gene-related peptide receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Eptinezumab (substance) Is a Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Eptinezumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eptinezumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Eptinezumab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eptinezumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only eptinezumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eptinezumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Eptinezumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Eptinezumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start